BYI VISION
A society where every youth will rise and contribute meaningfully to the healthy and developmental growth of the society.
BYI MISSION
To work collectively as youth to avert health and developmental related problems society through active participation/involvement in the society to provide a better, safer and healthier society for the less privilege.
BYI GOAL
Our goal is to educate and enlighten the community more on the emerging diseases that they are ignorance of, the negative effects of abusing drugs/alcohol and producing an youths which will lead to the growth and development of National and Global healthy living, assisting the less privilege in the society through active participation, networking and partnering with other NGOs and related agencies for sustainable development.
BYI AIM AND OBJECTIVES
I. To enlighten and educate the youth on drug abuse and alcoholism,
II. To educate communities on endemic (emerging) diseases Like Viral and Non-Viral Hepatitis, HIV/AIDS, Malaria, Diabetes, Tuberculosis, and other Health related issues.
III. To create awareness on rights of the child, youth and women in the society.
IV. To organize forums, seminars as a means of empowering and building the capacity of youth/community in the society.
V. To collaborate with Government Ministries, Departments, Agencies to achieve the set objectives.
VI. To cater for the needs of Orphans and the Vulnerable in the society.
VII. To undertake any other work or functions that may be for the general welfare of the people.
VIII. To network with similar NGOs so as to mobilize resources for the enhancement of the living standard of people in the society.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close